-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The first patient-specific zebrafish model for arrhythmic cardiomyopathy
The research team of Jeroen Bakkers (Hubrecht Institute/UMC Utrecht) and Toon van Veen (UMC Utrecht) proposed the first patient-specific model for arrhythmic cardiomyopathy (ACM)
Arrhythmic cardiomyopathy (ACM) is a heart disease that causes a layer of fat to accumulate on the outer layer of the heart to replace the healthy heart muscle
Zebrafish model
Researchers from the teams of Jeroen Bakkers (Hubrecht Institute/UMC Utrecht) and Toon van Veen (UMC Utrecht) were able to reproduce the human form of ACM in zebrafish
Rescue cell dysfunction
"Once we know that we can mimic ACM by introducing PLN mutations in zebrafish, we need a way to rescue the cellular changes that subsequently occur in the heart," Sarah, one of the first authors of the journal Nature Communications Carmel explained
The first different model
Since previous animal studies could not reproduce the accumulation of fat in the heart, this zebrafish model provides the first ACM patient-specific model
Further research
Researchers are continuing to study the important mechanisms of the development of this disease
Article Title
Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model 2 for phospholamban R14del cardiomyopathy